Search research articles
Contact Us
Filters
Showing results (41-50 of 70) with videos related to
Page
of 7
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 6, 2019
First-in-Humans Imaging with <sup>89</sup>Zr-Df-IAB22M2C Anti-CD8 Minibody in Patients with Solid Malignancies: Preliminary Pharmacokinetics, Biodistribution, and Lesion Targeting
Neeta Pandit-Taskar, Michael A Postow, Matthew D Hellmann, et al.
Nature Immunology
|
October 21, 2022
Shared and distinct biological circuits in effector, memory and exhausted CD8<sup>+</sup> T cells revealed by temporal single-cell transcriptomics and epigenetics
Josephine R Giles, Shin Foong Ngiow, Sasikanth Manne, et al.
Immunity
|
March 9, 2022
Human epigenetic and transcriptional T cell differentiation atlas for identifying functional T cell-specific enhancers
Josephine R Giles, Sasikanth Manne, Elizabeth Freilich, et al.
Cell Reports
|
October 8, 2023
Upregulation of exosome secretion from tumor-associated macrophages plays a key role in the suppression of anti-tumor immunity
Wenqun Zhong, Youtao Lu, Xuexiang Han, et al.
Cancer
|
July 22, 2021
Compliance with sentinel lymph node biopsy guidelines for invasive melanomas treated with Mohs micrographic surgery
Kelly M MacArthur, Brian C Baumann, Joseph F Sobanko, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 28, 2020
Long-term safety of pembrolizumab monotherapy and relationship with clinical outcome: A landmark analysis in patients with advanced melanoma
Caroline Robert, Wen-Jen Hwu, Omid Hamid, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2022
BAMM (BRAF Autophagy and MEK Inhibition in Melanoma): A Phase I/II Trial of Dabrafenib, Trametinib, and Hydroxychloroquine in Advanced BRAFV600-mutant Melanoma
Janice M Mehnert, Tara C Mitchell, Alexander C Huang, et al.
Cancer Research Communications
|
June 28, 2023
Phase I Trial of Autologous RNA-electroporated cMET-directed CAR T Cells Administered Intravenously in Patients with Melanoma and Breast Carcinoma
Payal D Shah, Alexander C Huang, Xiaowei Xu, et al.
Nature
|
June 18, 2019
TOX transcriptionally and epigenetically programs CD8<sup>+</sup> T cell exhaustion
Omar Khan, Josephine R Giles, Sierra McDonald, et al.
Journal of the American Academy of Dermatology
|
October 18, 2025
Compliance with guidelines and timeliness of sentinel lymph node biopsy for Merkel cell carcinoma treated with Mohs micrographic surgery versus conventional excision at a tertiary academic center
Mara D Trifoi, Karla Valdes Morales, Daniela Frankel, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 70) with videos related to
Sort By:
Page
of 7
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 6, 2019
First-in-Humans Imaging with <sup>89</sup>Zr-Df-IAB22M2C Anti-CD8 Minibody in Patients with Solid Malignancies: Preliminary Pharmacokinetics, Biodistribution, and Lesion Targeting
Neeta Pandit-Taskar, Michael A Postow, Matthew D Hellmann, et al.
Nature Immunology
|
October 21, 2022
Shared and distinct biological circuits in effector, memory and exhausted CD8<sup>+</sup> T cells revealed by temporal single-cell transcriptomics and epigenetics
Josephine R Giles, Shin Foong Ngiow, Sasikanth Manne, et al.
Immunity
|
March 9, 2022
Human epigenetic and transcriptional T cell differentiation atlas for identifying functional T cell-specific enhancers
Josephine R Giles, Sasikanth Manne, Elizabeth Freilich, et al.
Cell Reports
|
October 8, 2023
Upregulation of exosome secretion from tumor-associated macrophages plays a key role in the suppression of anti-tumor immunity
Wenqun Zhong, Youtao Lu, Xuexiang Han, et al.
Cancer
|
July 22, 2021
Compliance with sentinel lymph node biopsy guidelines for invasive melanomas treated with Mohs micrographic surgery
Kelly M MacArthur, Brian C Baumann, Joseph F Sobanko, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 28, 2020
Long-term safety of pembrolizumab monotherapy and relationship with clinical outcome: A landmark analysis in patients with advanced melanoma
Caroline Robert, Wen-Jen Hwu, Omid Hamid, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2022
BAMM (BRAF Autophagy and MEK Inhibition in Melanoma): A Phase I/II Trial of Dabrafenib, Trametinib, and Hydroxychloroquine in Advanced BRAFV600-mutant Melanoma
Janice M Mehnert, Tara C Mitchell, Alexander C Huang, et al.
Cancer Research Communications
|
June 28, 2023
Phase I Trial of Autologous RNA-electroporated cMET-directed CAR T Cells Administered Intravenously in Patients with Melanoma and Breast Carcinoma
Payal D Shah, Alexander C Huang, Xiaowei Xu, et al.
Nature
|
June 18, 2019
TOX transcriptionally and epigenetically programs CD8<sup>+</sup> T cell exhaustion
Omar Khan, Josephine R Giles, Sierra McDonald, et al.
Journal of the American Academy of Dermatology
|
October 18, 2025
Compliance with guidelines and timeliness of sentinel lymph node biopsy for Merkel cell carcinoma treated with Mohs micrographic surgery versus conventional excision at a tertiary academic center
Mara D Trifoi, Karla Valdes Morales, Daniela Frankel, et al.
Page
of 7